cotinine has been researched along with Cognition Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Echeverria, V; Grizzell, JA | 1 |
| Bartlett, MG; Beck, WD; Callahan, PM; Li, P; Terry, AV | 1 |
| DeVito, EE; Gelernter, J; Herman, AI; Jensen, KP; Sofuoglu, M; Valentine, GW | 1 |
| Appunn, D; Echeverria, V; Iarkov, A | 1 |
| Lang, IA; Langa, KM; Llewellyn, DJ; Matthews, FE; Naughton, F | 1 |
| Buccafusco, JJ; Terry, AV | 1 |
| Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Bhang, SY; Cho, IH; Cho, SC; Hong, YC; Kim, BN; Kim, HW; Kim, JW; Shin, MS; Yoo, HJ | 1 |
| Brinkmeyer, J; Drusch, K; Fisahn, K; Lowe, A; Mobascher, A; Musso, F; Ohmann, C; Shah, J; Warbrick, T; Winterer, G; Wölwer, W | 1 |
| Akhtar, WZ; Andresen, EM; Cannell, MB; Xu, X | 1 |
| Bouchard, KP; Buccafusco, JJ; Hernandez, CM; Hohnadel, EJ; Terry, AV | 1 |
2 review(s) available for cotinine and Cognition Disorders
| Article | Year |
|---|---|
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.
Topics: Animals; Antidepressive Agents; Cognition; Cognition Disorders; Cotinine; Humans; Nicotine; Receptors, Nicotinic | 2015 |
Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.
Topics: Aging; Animals; Autoradiography; Cell Survival; Cognition Disorders; Cotinine; Humans; Neuropsychological Tests; Primates; Rats; Receptors, Muscarinic; Receptors, Nicotinic; Reflex, Startle | 2005 |
2 trial(s) available for cotinine and Cognition Disorders
| Article | Year |
|---|---|
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.
Topics: Adult; Analysis of Variance; Cognition Disorders; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Self Report; Smoking; Social Behavior; Statistics as Topic; Stress, Psychological; Young Adult | 2013 |
7 other study(ies) available for cotinine and Cognition Disorders
| Article | Year |
|---|---|
Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function.
Topics: Administration, Intravenous; Administration, Oral; Animals; Cognition; Cognition Disorders; Cotinine; Models, Biological; Rats; Rats, Wistar | 2015 |
A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Topics: Adult; Blood Pressure; Cognition Disorders; Cotinine; Female; Genome-Wide Association Study; Heart Rate; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Cognition Disorders; Cotinine; Depression; Female; Memory; Motor Activity; Postural Balance; Rats; Rats, Wistar; Recognition, Psychology; Spatial Memory; Swimming; Weight Gain | 2016 |
Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement.
Topics: Aged; Aged, 80 and over; Biomarkers; Cognition Disorders; Cotinine; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Regression Analysis; Saliva; Tobacco Smoke Pollution | 2009 |
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.
Topics: Animals; Antipsychotic Agents; Benzylidene Compounds; Cognition Disorders; Conditioning, Operant; Cotinine; Female; Hallucinogens; Ketamine; Macaca nemestrina; Male; Memory; Nicotinic Agonists; Pyridines; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology | 2009 |
Effect of environmental exposure to lead and tobacco smoke on inattentive and hyperactive symptoms and neurocognitive performance in children.
Topics: Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Causality; Child; Cognition Disorders; Cotinine; Environmental Exposure; Female; Humans; Korea; Lead; Male; Neuropsychological Tests; Sex Distribution; Tobacco Smoke Pollution | 2010 |
Association of blood cotinine level with cognitive and physical performance in non-smoking older adults.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Body Mass Index; Cognition; Cognition Disorders; Confidence Intervals; Cotinine; Cross-Sectional Studies; Female; Humans; Hypertension; Lead; Male; Middle Aged; Motor Activity; Multivariate Analysis; Nutrition Surveys; Regression Analysis; Self Report; Tobacco Smoke Pollution | 2013 |